ES2052454A1 - Dipeptides and compositions which contain them with pharmaceutical action against ageing - Google Patents

Dipeptides and compositions which contain them with pharmaceutical action against ageing

Info

Publication number
ES2052454A1
ES2052454A1 ES09202671A ES9202671A ES2052454A1 ES 2052454 A1 ES2052454 A1 ES 2052454A1 ES 09202671 A ES09202671 A ES 09202671A ES 9202671 A ES9202671 A ES 9202671A ES 2052454 A1 ES2052454 A1 ES 2052454A1
Authority
ES
Spain
Prior art keywords
dipeptides
compositions
contain
action against
ageing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09202671A
Other languages
Spanish (es)
Other versions
ES2052454B1 (en
Inventor
Franco Pellacini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SA
Original Assignee
Zambon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SA filed Critical Zambon SA
Priority to ES9202671A priority Critical patent/ES2052454B1/en
Publication of ES2052454A1 publication Critical patent/ES2052454A1/en
Application granted granted Critical
Publication of ES2052454B1 publication Critical patent/ES2052454B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Dipeptides and compositions which contain them with pharmaceutical action against ageing, based on compounds of formula (I), in which R1 represents a C1-C4 alkyl radical or an -OR3 group, where R3 is a C1-C3 alkyl, and R2 represents a hydrogen atom or a C1-C4 alkyl radical. The addition salts with pharmaceutically acceptable organic or inorganic acids are also considered to be included. These compounds have applications in the prevention and curative treatment of pathological syndromes derived from low levels of intracellular glutathione (GSH), and more specifically those due to ageing.
ES9202671A 1992-12-31 1992-12-31 DIPEPTIDES AND COMPOSITIONS THAT CONTAIN THEM WITH PHARMACEUTICAL ACTION AGAINST AGING. Expired - Fee Related ES2052454B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9202671A ES2052454B1 (en) 1992-12-31 1992-12-31 DIPEPTIDES AND COMPOSITIONS THAT CONTAIN THEM WITH PHARMACEUTICAL ACTION AGAINST AGING.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9202671A ES2052454B1 (en) 1992-12-31 1992-12-31 DIPEPTIDES AND COMPOSITIONS THAT CONTAIN THEM WITH PHARMACEUTICAL ACTION AGAINST AGING.

Publications (2)

Publication Number Publication Date
ES2052454A1 true ES2052454A1 (en) 1994-07-01
ES2052454B1 ES2052454B1 (en) 1995-01-16

Family

ID=8279297

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9202671A Expired - Fee Related ES2052454B1 (en) 1992-12-31 1992-12-31 DIPEPTIDES AND COMPOSITIONS THAT CONTAIN THEM WITH PHARMACEUTICAL ACTION AGAINST AGING.

Country Status (1)

Country Link
ES (1) ES2052454B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002353A1 (en) * 1984-10-16 1986-04-24 Zambon S.P.A. Dipeptide compounds having pharmaceutical activity and compositions containing them
EP0332999A2 (en) * 1988-03-16 1989-09-20 ZAMBON GROUP S.p.A. Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
EP0333000A2 (en) * 1988-03-16 1989-09-20 ZAMBON GROUP S.p.A. Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002353A1 (en) * 1984-10-16 1986-04-24 Zambon S.P.A. Dipeptide compounds having pharmaceutical activity and compositions containing them
EP0332999A2 (en) * 1988-03-16 1989-09-20 ZAMBON GROUP S.p.A. Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
EP0333000A2 (en) * 1988-03-16 1989-09-20 ZAMBON GROUP S.p.A. Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES2052454B1 (en) 1995-01-16

Similar Documents

Publication Publication Date Title
DK0641767T3 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing these derivatives
ES8701196A1 (en) Dipeptide compounds having pharmaceutical activity and compositions containing them.
ATE166534T1 (en) GERMICIDE ACTIVE INGREDIENTS COMBINATIONS
TR199800697T2 (en) Pharmaceutically active quinazoline compounds.
ATE266382T1 (en) SUNSCREEN
DE69430988D1 (en) PYRAZOLOTRIAZINE WITH INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR INHIBITOR EFFECT
NO953844D0 (en) 1-amidinophenyl pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
NO944919L (en) Method of inhibiting atrophy of the skin or vagina
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
CO5011045A1 (en) TIENILAZOLILALCOXIETANAMINAS, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS
HUT60271A (en) Process for producing tricyclic compounds, functioning as enzyme inhibitior and comprising amino or nitro group and pharmaceutical compositions comprising same as active ingredient
AP1555A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
DK0662325T3 (en) Inhibition of ovarian dysgenesis, delayed puberty or sexual infantilism
EP0469156A4 (en) Glutathione derivative
UA37311C2 (en) Compound for treating sexual dysfunction and pharmaceutical composition
ES2052454A1 (en) Dipeptides and compositions which contain them with pharmaceutical action against ageing
KR950011429A (en) Epoxy succinic acid derivatives
SE7709913L (en) WAY TO PRODUCE PENTA PEPTIDER
MX9505054A (en) Bisphenol ester derivatives.
DE3370159D1 (en) Amide derivatives
HU9203849D0 (en) Thiazole derivatives
EA200001107A1 (en) DERIVATIVES OF OCTAGIDRO-6,10-DIOXO-6H-PIRIDAZINO [1,2-a] [1,2] DIAZEPIN-1-CARBONIC ACID, METHOD OF OBTAINING AND THEIR APPLICATION FOR OBTAINING TREATMENT OF ACTIVE COMPOUNDS
TW329388B (en) Intraocular irrigating solution
NO308077B1 (en) Substituted thiazole [3,2-a] azepine derivative, inhibitor, diuretic and preparation comprising the derivative, as well as intermediate

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20180806